2026/08/17
BEIJING, China, August 17, 2026 -- Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced it filed its unaudited fi
BEIJING, China, August X, 2026 — SINOVAC announced that its Serum-Free Rabies Vaccine for Human Use has received a Drug Registration Certificate from China's National Medical Products Administrati
2026/08/06
BEIJING, China, July 31, 2026 — A study evaluating the optimal timing of a booster dose of varicella vaccine among school-aged children has been published in the Chinese Journal of Epidemiology. The r
2026/07/31
BEIJING, China, July 31, 2026 — SINOVAC announced that a large-scale prospective cohort study evaluating the effectiveness of itsvaricella vaccine, live has been published in the peer-reviewed journal
2026/07/31
The content is intended for use by media professionals
These images may be downloaded for non-commercial use and for purposes such as news reporting or research. Images may not be modified and must display the following copyright language: Copyright © SINOVAC Biotech Ltd. All rights reserved.
Learn more about SINOVAC copyright and trademark policies.
Media Contacts: pr@sinovac.com
EN
